Eternygen
Berlin, DE · 1 known investors
Find your way into Eternygen
Sign up to see every warm intro you have to Eternygen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eternygen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eternygen is a Berlin-based pharmaceutical company founded in 2012 that researches and develops drugs for diet-related metabolic diseases such as fatty liver, diabetes, and obesity. Its work centers on the sodium-coupled citrate transporter NaCT as a therapeutic target to correct the underlying metabolic defect.
Investors · 1
Frequently asked questions
- What does Eternygen do?
- Eternygen is a Berlin-based pharmaceutical company founded in 2012 that researches and develops drugs for diet-related metabolic diseases such as fatty liver, diabetes, and obesity. Its work centers on the sodium-coupled citrate transporter NaCT as a therapeutic target to correct the underlying metabolic defect.
- Who are Eternygen's investors?
- Eternygen's investors include IBB Ventures.
- Where is Eternygen headquartered?
- Eternygen is headquartered in Berlin, DE.